Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daridorexant and Citalopram Interaction Study
NCT03907215Phase 1Completed
- Sponsor
- Idorsia
- Start
- Apr 2019
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of daridorexant in Insomnia (2 arms), sponsored by Idorsia. Primary endpoint: Saccadic Peak Velocity. Started Apr 2019; status: completed.
02
Drugs
daridorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03907215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03907215.